Andrew M. Wark focuses his practice on public and private mergers and acquisitions, shareholder activism defense and general corporate matters. Wark’s clients have included AngloGold Ashanti, AXA, Barrick Gold, Benchmark Electronics, CardWorks, Convey Health Solutions, Corteva, Cox Enterprises, Crown Castle, Eurazeo, Fortress Transportation & Infrastructure Investors, Future Standard, GuideWell, IBM, Just Eat Takeaway.com, Olin, Peabody Energy, RELX Group, Sensata Technologies, Viatris and ViewRay.
Wark has also represented numerous companies and boards of directors regarding shareholder activism, including representing Benchmark Electronics in its cooperation agreement with Engaged Capital, Corteva in its agreement with Starboard, Sensata Technologies in its cooperation agreement with Elliott Management and ViewRay in its cooperation agreement with Hudson Executive Capital.
Lawdragon Honors
| Honor | Year | Practice |
|---|---|---|
| The 2026 Lawdragon 500 Leading Dealmakers in America | 2026 | Corporate, M&A |
| The 2025 Lawdragon 500 Leading Dealmakers in America | 2025 | Corporate, M&A |
| The Lawdragon 500 Global Leaders in Crisis Management | 2025 | M&A, Governance, Activist Defense |
| The 2025 Lawdragon 500 X – The Next Generation | 2025 | Corporate, M&A |
| The 2024 Lawdragon 500 Leading Dealmakers in America | 2024 | Corporate, M&A |
| The 2024 Lawdragon 500 X – The Next Generation | 2024 | Corporate, M&A |
| Lawdragon 500 X – The Next Generation | 2023 | Corporate, M&A |
Wark’s notable M&A transactions include representing:
- AngloGold Ashanti in its C$197 million acquisition of Augusta Gold;
- Paragon 28 in its $1.2 billion acquisition by Zimmer Biomet;
- CardWorks in its acquisition of Ally’s credit card business;
- Just Eat Takeaway.com in the sale of Grubhub to Wonder;
- Atalaya Capital Management in its $800 million sale to Blue Owl Capital;
-
Viatris in its divestitures totaling $3.6 billion in value, including the divestitures of its Over‑the‑Counter, Women’s Healthcare and Active Pharmaceutical Ingredients businesses;
-
Viatris in its $750 million acquisitions of Oyster Point and Famy Life Sciences;
- Newcrest in its A$28.8 billion acquisition by Newmont;
- FS Investments (now Future Standard) in its combination with Portfolio Advisors, creating a $75 billion alternative investment firm;
- Cowen in its $1.9 billion acquisition by TD;
- Convey Health Solutions in its $1.1 billion take‑private acquisition by TPG Capital;
- GuideWell in its $900 million combination with Triple-S Management;
- The special committee of the board of Eidos Therapeutics in the $2.83 billion merger with BridgeBio Pharma;
- Just Eat Takeaway.com in its $7.3 billion acquisition of Grubhub;
- Barrick Gold in its proposed $42 billion merger and subsequent joint venture with Newmont Mining and its $18.3 billion merger with Randgold Resources;
- RELX Group in its acquisition of Emailage;
- Peabody Energy in its proposed joint venture with Arch Resources;
- AXA in its $15.3 billion acquisition of XL;
- Cincinnati Bell in its $650 million combination with Hawaiian Telcom and its $201 million acquisition of OnX Enterprise Solutions;
- Eurazeo in its majority investment in WorldStrides;
- Crown Castle in its $7.1 billion acquisition of Lightower and its $1.5 billion acquisition of FiberNet;
- Alere in its $8 billion sale to Abbott Laboratories;
- MarkWest Energy Partners in its $21 billion merger with MPLX;
- IBM in its acquisition of Clearleap; and
- Olin in its $5 billion Reverse Morris Trust acquisition of the chlorine value chain business of Dow Chemical.